188 related articles for article (PubMed ID: 10453939)
1. Ursodeoxycholic acid prevents hepatic cytochrome P450 isozyme reduction in rats with deoxycholic acid-induced liver injury.
Tanaka M; Nakura H; Tateishi T; Watanabe M; Nakaya S; Kumai T; Kobayashi S
J Hepatol; 1999 Aug; 31(2):263-70. PubMed ID: 10453939
[TBL] [Abstract][Full Text] [Related]
2. Regulation of bile acid synthesis by deoxycholic acid in the rat: different effects on cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase.
Shefer S; Kren BT; Salen G; Steer CJ; Nguyen LB; Chen T; Tint GS; Batta AK
Hepatology; 1995 Oct; 22(4 Pt 1):1215-21. PubMed ID: 7557873
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of male-specific cytochrome P450s 2C11 and 3A2 in bile duct-ligated male rats: importance to reduced hepatic content of cytochrome P450 in cholestasis.
Chen J; Murray M; Liddle C; Jiang XM; Farrell GC
Hepatology; 1995 Aug; 22(2):580-7. PubMed ID: 7635428
[TBL] [Abstract][Full Text] [Related]
4. Ebselen protects against the reduction in levels of drug-metabolizing enzymes in livers of rats with deoxycholic acid-induced liver injury.
Tanaka M; Takezawa N; Kumai T; Watanabe M; Matsumoto N; Nakaya S; Kobayashi S
Pharmacol Toxicol; 2002 Aug; 91(2):64-70. PubMed ID: 12420794
[TBL] [Abstract][Full Text] [Related]
5. Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes.
Shimojo N; Ishizaki T; Imaoka S; Funae Y; Fujii S; Okuda K
Biochem Pharmacol; 1993 Aug; 46(4):621-7. PubMed ID: 8363636
[TBL] [Abstract][Full Text] [Related]
6. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid (UDCA) prevents DCA effects on male mouse liver via up-regulation of CYP [correction of CXP] and preservation of BSEP activities.
Paolini M; Pozzetti L; Montagnani M; Potenza G; Sabatini L; Antelli A; Cantelli-Forti G; Roda A
Hepatology; 2002 Aug; 36(2):305-14. PubMed ID: 12143038
[TBL] [Abstract][Full Text] [Related]
8. Bile acids produce a generalized reduction of the catalytic activity of cytochromes P450 and other hepatic microsomal enzymes in vitro: relevance to drug metabolism in experimental cholestasis.
Chen J; Farrell GC
J Gastroenterol Hepatol; 1996 Sep; 11(9):870-7. PubMed ID: 8889968
[TBL] [Abstract][Full Text] [Related]
9. Effects of bile duct ligation on hepatic expression of female-specific CYP2C12 in male and female rats.
Chen J; Robertson G; Field J; Liddle C; Farrell GC
Hepatology; 1998 Sep; 28(3):624-30. PubMed ID: 9731550
[TBL] [Abstract][Full Text] [Related]
10. Treatment with milk thistle extract (Silybum marianum), ursodeoxycholic acid, or their combination attenuates cholestatic liver injury in rats: Role of the hepatic stem cells.
Alaca N; Özbeyli D; Uslu S; Şahin HH; Yiğittürk G; Kurtel H; Öktem G; Çağlayan Yeğen B
Turk J Gastroenterol; 2017 Nov; 28(6):476-484. PubMed ID: 29086715
[TBL] [Abstract][Full Text] [Related]
11. Suppression of rat hepatic cytochrome P450 2E1 expression by isopropyl 2-(1,3-dithioetane-2-ylidene)-2-[N-(4-methyl-thiazol-2-yl)carbamoyl] acetate (YH439), an experimental hepatoprotectant: protective role against hepatic injury.
Choi EY; Kim SG; Lee JW; Yoo JK; Shin JK; Kim ND
Biochem Pharmacol; 1996 Oct; 52(8):1219-25. PubMed ID: 8937429
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of chick embryo hepatic cytochrome P450 1A, 2H and 3A following in ovo administration of 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-ethylpyridine and 3-[2-(2,4,6-trimethylphenyl)thioethyl]-4-methylsydnone.
McNamee JP; Kimmett SM; Marks GS
Biochem Pharmacol; 1995 May; 49(10):1443-52. PubMed ID: 7763287
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the levels of cytochromes P450 in rat liver and lung by dietary lipid.
Yoo JS; Smith TJ; Ning SM; Lee MJ; Thomas PE; Yang CS
Biochem Pharmacol; 1992 Jun; 43(12):2535-42. PubMed ID: 1632812
[TBL] [Abstract][Full Text] [Related]
14. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes.
Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF
Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497
[TBL] [Abstract][Full Text] [Related]
15. Effects of dioxane on cytochrome P450 enzymes in liver, kidney, lung and nasal mucosa of rat.
Nannelli A; De Rubertis A; Longo V; Gervasi PG
Arch Toxicol; 2005 Feb; 79(2):74-82. PubMed ID: 15490126
[TBL] [Abstract][Full Text] [Related]
16. Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis.
Razori MV; Maidagan PM; Ciriaci N; Andermatten RB; Barosso IR; Martín PL; Basiglio CL; Sánchez Pozzi EJ; Ruiz ML; Roma MG
Biochem Pharmacol; 2019 Oct; 168():48-56. PubMed ID: 31202734
[TBL] [Abstract][Full Text] [Related]
17. Time course for the modulation of hepatic cytochrome P450 after administration of ethylbenzene and its correlation with toluene metabolism.
Yuan W; Sequeira DJ; Cawley GF; Eyer CS; Backes WL
Arch Biochem Biophys; 1997 Mar; 339(1):55-63. PubMed ID: 9056233
[TBL] [Abstract][Full Text] [Related]
18. [Disturbed functioning of enzyme systems of the microsomal oxidation, glucuro- and glutathione conjugation of xenobiotics in the liver of rats intoxicated by deoxycholate and their correction].
Bushma MI; Legon'kova LF; Zverinskiĭ IV; Vasil'ev AV
Biull Eksp Biol Med; 2000 Jan; 129(1):56-60. PubMed ID: 10710630
[No Abstract] [Full Text] [Related]
19. 3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.
Clerici C; Castellani D; Asciutti S; Pellicciari R; Setchell KD; O'Connell NC; Sadeghpour B; Camaioni E; Fiorucci S; Renga B; Nardi E; Sabatino G; Clementi M; Giuliano V; Baldoni M; Orlandi S; Mazzocchi A; Morelli A; Morelli O
Toxicol Appl Pharmacol; 2006 Jul; 214(2):199-208. PubMed ID: 16487557
[TBL] [Abstract][Full Text] [Related]
20. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid.
Azer SA; Canfield PJ; Stacey NH
J Gastroenterol Hepatol; 1995; 10(3):261-9. PubMed ID: 7548801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
